Characteristics and Outcomes of Dialysis Patients with Infective Endocarditis

被引:23
|
作者
Jones, Daniel A. [1 ,5 ]
McGill, Laura-Ann [1 ]
Rathod, Krishnaraj S. [1 ]
Matthews, Kirsty [1 ]
Gallagher, Sean [1 ]
Uppal, Rakesh [3 ]
Mills, Peter G. [1 ,5 ]
Das, Satya [4 ]
Yaqoob, Magdi [2 ]
Ashman, Neil [2 ]
Wragg, Andrew [1 ,5 ]
机构
[1] Barts & London NHS Trust, Dept Cardiol, London, England
[2] Barts & London NHS Trust, Dept Renal Med, London, England
[3] Barts & London NHS Trust, Dept Cardiothorac Surg, London, England
[4] Barts & London NHS Trust, Dept Microbiol, London, England
[5] Barts & London NHS Trust, NIHR Cardiovasc Biomed Res Unit, London, England
来源
NEPHRON CLINICAL PRACTICE | 2013年 / 123卷 / 3-4期
关键词
Infective endocarditis; Dialysis; Renal failure; HEMODIALYSIS-PATIENTS; RISK-FACTORS;
D O I
10.1159/000353732
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: The incidence of infective endocarditis (IE) in dialysis patients is higher than the general population. Dialysis patients who develop endocarditis are thought to have a poorer prognosis than other patients with IE. Aim: To examine the risk profiles, clinical features, and outcomes of patients on dialysis who developed IE in a large cohort. Design and Methods: A retrospective analysis of all patients developing IE on dialysis (using the modified Duke criteria) was undertaken between 1998 and 2011. Patients were identified from a prospectively collected clinical database. Results: 42 patients developed IE out of a total incident dialysis population of 1,500 over 13 years. 95% of the patients (40/42) were on long-term haemodialysis (HD) and 5% (2/42) on peritoneal dialysis. Mean patient age was 55.2 years (IQR: 43-69), and mean duration of HD prior to IE was 57.4 months. Primary HD access at the time of diagnosis was an arteriovenous fistula in 35% (14/40), a dual-lumen tunnelled catheter in 55% (22/40), and a dual-lumen non-tunnelled catheter in 10% (4/40). Staphylococcus aureus (including methicillin-resistant S. aureus) was present in 57.1% (24/42). The aortic valve was affected in 42.8% of the patients (18/42), the mitral valve in 30.9% (13/42), and both valves in 9.5% (4/42). 33.3% of the patients had an abnormal valve before the episode of IE. In 21.4% (9/42), valve surgery was performed and mortality was lower in the surgical group compared to the group managed medically during hospitalisation (11.1 vs. 15.2%, p = 0.892), at 3 months (13.1 vs. 19.6%, p = 0.501), and during follow-up (p = 0.207), but this difference did not reach statistical significance. Age >60 years, septic emboli, and methicillin-resistant S. aureus were all adverse prognostic factors. Patients receiving surgery were younger (mean 47.1 +/- 14.4 years vs. 57.4 +/- 14.3, p = 0.049) and less likely to be infected with S. aureus (surgery 33.3% vs. antibiotics 63.6%, p = 0.046). Conclusion: This is one of the largest reported series of IE in dialysis patients. The incidence of IE remains high and the prognosis poor in dialysis patients, although patients selected for early valve surgery have good 1-year survival. Copyright (C) 2013 S. Karger AG, Basel
引用
收藏
页码:151 / 156
页数:6
相关论文
共 50 条
  • [11] Predictors of Surgical Intervention in Dialysis Patients With Infective Endocarditis
    Woller, John A., III
    Walsh, Victoria L.
    Robichaux, Chad
    Thourani, Vinod H.
    Jacob, Jesse T.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (11):
  • [12] Infective endocarditis in dialysis patients: New challenges and old
    Doulton, T
    Sabharwal, N
    Cairns, HS
    Schelenz, S
    Eykyn, S
    O'Donnell, P
    Chambers, J
    Austen, C
    Goldsmith, DJA
    [J]. KIDNEY INTERNATIONAL, 2003, 64 (02) : 720 - 727
  • [13] Prevalence, Characteristics, and Outcomes of Infective Endocarditis in Patients With Liver Disease in the United States
    Khayata, Mohamed
    Grimm, Richard A.
    Griffin, Brian P.
    Xu, Bo
    [J]. CIRCULATION, 2023, 148
  • [14] Characteristics and outcomes in patients with infective endocarditis caused by Enterococcus faecium and Enterococcus faecalis
    Lenz, I. Try
    Pries-Heje, M.
    Hjulmand, J.
    Hasselbalch, R. B.
    Jarloev, J. O.
    Faurholt-Jepsen, D.
    Moser, C.
    Iversen, K.
    Bundgaard, H.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 : 1669 - 1669
  • [15] Clinical characteristics and outcomes of nosocomial infective endocarditis in Asia
    Hwang, J. -W.
    Cho, E. -J.
    Lee, G. -Y.
    Kim, E. -K.
    Chang, S. -A.
    Park, S. -J.
    Lee, S. -C.
    Park, S. -W.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 : 533 - 533
  • [16] Incidence, outcomes and microbiology in patients with infective endocarditis
    Shah, A.
    McAllister, D.
    Astengo, F.
    Perez, J.
    Lee, K. K.
    Gallacher, P.
    Hall, J.
    Bing, R.
    Anand, A.
    Newby, D.
    Mills, N.
    Cruden, N.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 1952 - 1952
  • [17] Association of anticoagulation with outcomes in patients with infective endocarditis
    Sheng, S.
    Tao, M.
    Ghosalkar, D.
    Despotidis, G.
    Liu, Y.
    Dhaliwal, S.
    Rahman, T.
    [J]. EUROPEAN HEART JOURNAL, 2023, 44
  • [18] Sex differences in characteristics, microbiology, management, and outcomes in infective endocarditis
    Stahl, A.
    Oestergaard, L.
    Havers-Borgersen, E.
    Strange, J. Emanuel
    Voldstedlund, M.
    Kober, L.
    Fosboel, E.
    [J]. EUROPEAN HEART JOURNAL, 2023, 44
  • [19] Neurological outcomes of patients with mycotic aneurysms in infective endocarditis
    Shi, Hang
    Shah, Harsh
    Valenzuela, Ives
    Parikh, Neal
    Gutierrez, Jose
    Willey, Joshua
    [J]. NEUROLOGY, 2019, 92 (15)
  • [20] Incidence, Microbiology, and Outcomes in Patients Hospitalized With Infective Endocarditis
    Shah, Anoop S., V
    McAllister, David A.
    Gallacher, Peter
    Astengo, Federica
    Perez, Jesus Alberto Rodriguez
    Hall, Jennifer
    Lee, Kuan Ken
    Bing, Rong
    Anand, Atul
    Nathwani, Dilip
    Mills, Nicholas L.
    Newby, David E.
    Marwick, Charis
    Cruden, Nicholas L.
    [J]. CIRCULATION, 2020, 141 (25) : 2067 - 2077